| Literature DB >> 36189359 |
Mayra A Téllez-Corral1,2,3, Eddy Herrera-Daza4, Hayde K Cuervo-Jimenez2, Natalia Arango-Jimenez5, Darena Z Morales-Vera5, Juliana Velosa-Porras1, Catalina Latorre-Uriza1,5, Francina M Escobar-Arregoces1,5, Patricia Hidalgo-Martinez6, Maria E Cortés3, Nelly S Roa-Molina1, Liliana Otero1, Claudia M Parra-Giraldo2.
Abstract
Objective: The aim of this study was to analyze the cultivable oral microbiota of patients with obstructive sleep apnea (OSA) and its association with the periodontal condition.Entities:
Keywords: Candida albicans; MALDI-TOF-MS; cultivable oral microbiota; obstructive sleep apnea; periodontitis
Mesh:
Year: 2022 PMID: 36189359 PMCID: PMC9519896 DOI: 10.3389/fcimb.2022.934298
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 6.073
Demographic data and clinical characteristics of the groups of patients.
| Group 1 (H) ( | Group 2(P) ( | Group 3 (OSA) ( | Group 4(P-OSA) ( | |
|---|---|---|---|---|
|
| ||||
|
| 46 (14) | 41 (10) | 50 (13) | 49 (11) |
|
| 80 | 76 | 63 | 34 |
|
| 20 | 24 | 37 | 66 |
|
| ||||
|
| 12 | 18 | 42 | 19 |
|
| 8 | 6 | 11 | 3 |
|
| 8 | 18 | 11 | 19 |
|
| ||||
|
| 26.0 (3.92) | 26.8 (2.22) | 23.89 (6.29) | 25,22 (5.59) |
|
| 5.96 (3.92) | 5.23 (2.22) | 8.1 (6.29) | 6.78 (5.62) |
|
| 1.94 (3.57) | 43.83 (24) * | 1.62 (3.15) | 38.48 (21.25) * |
|
| 12 | 18 | 5 | 31 |
|
| 23 (16) | 45.2 (25.95) ** | 38.6 (20.63) ** | 40.6 (18.7) ** |
Group 1 (H) healthy patients, non-periodontitis, and non-OSA; Group 2 (P) periodontitis and non-OSA patients; Group 3 (OSA) OSA and non-periodontitis patients; Group 4 (P-OSA) periodontitis and OSA patients. SD, standard deviation. HTN, arterial hypertension; HLD, hyperlipidemia; HT, hypothyroidism. Significant differences, G1 (S) vs. G2 (P) p ≤ 0.0001*; G1 (S) vs. G4 (PA) p ≤ 0.0001*; G1 (S) vs. G2 (P) p = 0.0014**; G1 (S) vs. G3 (P) p = 0.0072**, G1 (S) vs. G4 (P) p = 0.0004**. Multiple t-test (multiple comparisons using the Bonferroni–Dunn method).
Percentage of patients of each group according to periodontal condition and degree of OSA.
| Group 1 (H) ( | Group 2 (P) ( | Group 3 (OSA) ( | Group 4 (P-OSA) ( |
|
| |
|---|---|---|---|---|---|---|
| Percentage (%) | ||||||
|
| ||||||
| Clinical gingival health on an intact periodontium | 4 | 0 | 5 | 0 | ns | ns |
| Biofilm-induced gingivitis | 8 | 0 | 0 | 0 | ns | ns |
| Biofilm-induced gingivitis in a reduced periodontium | 56* | 0 | 79‡ | 0 | 0.000419 | 0.024 |
| Stable periodontal disease in reduced periodontium | 32* | 0 | 16 | 0 | 0.03248 | ns |
| Periodontitis Stage I | 0 | 6 | 0 | 0 | ns | ns |
| Periodontitis Stage II | 0 | 24 | 0 | 16 | ns | ns |
| Periodontitis Stage III | 0 | 65* | 0 | 81‡ | 0.0012 | 0.0001 |
| Periodontitis Stage IV | 0 | 6 | 0 | 3 | ns | ns |
|
| ||||||
| Mild OSA | 0 | 0 | 63*‡ | 19 | 0.006 | 0.023 |
| Moderate OSA | 0 | 0 | 16 | 31 | ns | ns |
| Severe AOS | 0 | 0 | 21 | 50*‡ | 0,02 | 0,04 |
Group 1 (H): p-value* of Clinical gingival health on an intact periodontium vs. Biofilm-induced gingivitis in a reduced periodontium and Clinical gingival health on an intact periodontium vs. Stable periodontal disease in reduced periodontium. Group 2 (P): p-value* of Periodontitis Stage I vs. Periodontitis Stage III. Group 3 (OSA): p-value* of Mild OSA vs. Moderate OSA; p-value‡ of Mild OSA vs. Severe AOS, and Clinical gingival health on an intact periodontium vs. Biofilm-induced gingivitis in a reduced periodontium. Group 4 (P-OSA): p-value* of Mild OSA vs. Severe AOS; p-value‡ of Moderate OSA vs. Severe AOS, and Periodontitis Stage I vs. Periodontitis Stage III.
Frequency and percentage of the periodontal condition according to apnea diagnosis.
| OSA Diagnosis | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Periodontal diagnosis | Non-OSA | Mild OSA | Moderate OSA | Severe OSA |
| ||||
| Fr | % | Fr | % | Fr | % | Fr | % | ||
|
| 25 | 60 | 11 | 65 | 4 | 29 | 4 | 20 | 0.2813 |
|
| 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0157 |
|
| 3 | 7 | 1 | 6 | 3 | 21 | 1 | 5 | |
|
| 12 | 29 | 5 | 29 | 6 | 43 | 15 | 75 | |
|
| 1 | 2 | 0 | 0 | 1 | 7 | 0 | 0 | |
|
| 42 | 100 | 17 | 100 | 14 | 100 | 20 | 100 | |
Fr: Frequency, %: Percentage; two-way ANOVA, p < 0.05.
Relative frequencies of the distribution of complexes and categories by samples in the groups of patients.
| Yellow complex | Blue complex | Purple complex | Green complex | Orange complex | Red complex |
|
| Other | |
|---|---|---|---|---|---|---|---|---|---|
|
| 0.32 | 0.14 |
| 0.17 | 0.28 | 0.25 |
|
|
|
|
|
|
| 0.37 |
|
|
| 0.42 | 0.16 | 0.28 |
|
| 0.24 | 0.36 | 0.09 | 0.33 | 0.28 | 0.00 | 0.08 | 0.12 | 0.18 |
The bold values means Kruskal-Wallis chi-squared p-value < 0.05.
Figure 1Microbial community composition is grouped by complexes or categories. Bars indicate the percentages of the inter-group relative frequencies of the complexes/categories in group patients. Pie charts show the intra-group distribution percentages of complexes/categories in group patients: Group 1 (H) healthy patients, non-periodontitis and non-OSA; Group 2 (P) periodontitis and non-OSA patients; Group 3: (OSA) OSA and non-periodontitis patients; Group 4 (P-OSA) periodontitis and OSA patients.
Figure 2Relative frequencies of the complexes/categories in the oral samples by groups of patients. Significant differences between the relative frequencies of the complexes in each group were evaluated using the Kruskal-Wallis chi-square method; *p-value < 0.05, **p-value < 0.01.
Figure 3Multicomponent matrix for the correlation of clinical factors and complex/categories of microorganisms present in each of the groups of patients evaluated: (A) Group 1 (H), n = 25; (B) Group 2 (P), n = 17; (C) Group 3 (OSA), n = 19; (D) Group 4 (P-OSA), n = 32, using the Spearman's rank correlation coefficient rs > 0.30, p<0.05. The blue tones represent a positive correlation and the red tones represent a negative correlation. HTN, arterial hypertension. HLD, hyperlipidemia. HT: hypothyroidism.
Figure 4Percentile graph of the percentage of presence of complexes/categories in each of the groups of participants evaluated. Each point represents the presence (%) of the complex/category in a patient. The x-axis represents the percentiles, the y-axis the presence (%) of the complexes/categories, and the dotted line in the first panel indicates that 95% of the participants in Group 4 (P-OSA) have less than 5% presence of the yellow complex, on the other hand, 5% of the subjects of this same group exhibit > 5% presence of the yellow complex.
Figure 5Multidimensional Scaling (MDS) based on Proximity Matrices (Euclidean Distance) and Kruskal Stress for the three-dimensional visualization (XLSTAT3DPlot) of the consortia made up of the most common microorganisms by group of patients: (A) Group 1 (H); (B) Group 2 (P); (C) Group 3 (OSA); (D) Group 4 (P-OSA).